CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION

被引：1704

作者：

CALVERT, AH

NEWELL, DR

GUMBRELL, LA

OREILLY, S

BURNELL, M

BOXALL, FE

SIDDIK, ZH

JUDSON, IR

GORE, ME

WILTSHAW, E

机构：

[1] ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND

[2] INST CANC RES, DRUG DEV & MED SECT, LONDON, ENGLAND

[3] INST CANC RES, MED SECT, LONDON, ENGLAND

来源：

关键词：

D O I：

10.1200/JCO.1989.7.11.1748

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1748 / 1756

页数：9

共 40 条

[11] EGORIN MJ, 1984, CANCER RES, V44, P5432
[12] EGORIN MJ, 1985, CANCER RES, V45, P6502
[13] ELFERINK F, 1987, CANCER TREAT REP, V71, P1231
[14] FISH RG, 1987, P AN M AM SOC CLIN, V6, P21
[15] RESULTS OF NCI-SPONSORED PHASE-I TRIALS WITH CARBOPLATIN
FOSTER, BJ
CLAGETTCARR, K
LEYLANDJONES, B
HOTH, D
[J]. CANCER TREATMENT REVIEWS, 1985, 12 : 43 - 49
[16] THE DISPOSITION OF CARBOPLATIN IN OVARIAN-CANCER PATIENTS
GAVER, RC
COLOMBO, N
GREEN, MD
GEORGE, AM
DEEB, G
MORRIS, AD
CANETTA, RM
SPEYER, JL
FARMEN, RH
MUGGIA, FM
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (03) : 263 - 270
[17] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURES FOR THE ANALYSIS OF CARBOPLATIN IN HUMAN-PLASMA AND URINE
GAVER, RC
DEEB, G
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 16 (03) : 201 - 206
[18] GORMLEY PE, 1979, CLIN PHARMACOL THER, V25, P351
[19] HARLAND SJ, 1984, CANCER RES, V44, P1693
[20] PRECLINICAL STUDIES IDENTIFYING CARBOPLATIN AS A VIABLE CISPLATIN ALTERNATIVE
HARRAP, KR
[J]. CANCER TREATMENT REVIEWS, 1985, 12 : 21 - 33